Can You Take Mounjaro If You Have Ulcerative Colitis?

Mounjaro works as a dual GIP and GLP-1 receptor agonist, meaning it acts on appetite-regulating pathways and slows gastric emptying — effects that are well-documented in the electronic Medicines Compendium (eMC) Summary of Product Characteristics for tirzepatide. Because it affects how the gastrointestinal tract functions, anyone with an existing bowel condition such as ulcerative colitis should have an open conversation with their prescriber before starting or continuing the medicine.

The gastrointestinal side effects most commonly reported with tirzepatide — including nausea, diarrhoea, constipation, and abdominal discomfort — overlap with symptoms that people with ulcerative colitis may already experience. This overlap can make it harder to distinguish a medication side effect from a change in disease activity, which is one reason careful monitoring matters.

A few things worth being aware of:

• Disease activity level matters. Prescribers will often consider whether a condition is well-controlled or in a flare before introducing a medicine that may affect the gut.
• Drug interactions. Some immunosuppressants or biologics used to manage ulcerative colitis may have interactions worth discussing with your prescriber or pharmacist.
• Individual response varies. Many people experience digestive symptoms that ease over time on Mounjaro; others find them more persistent. How this interacts with ulcerative colitis differs from person to person.

If any GI symptoms — cramping, increased urgency, blood in stools, or unusual changes in bowel habit — feel different from your normal pattern or worsen after starting or increasing Mounjaro, contact your healthcare professional promptly rather than waiting for a routine appointment.

Digestive health questions come up across a range of related conditions too. You may find it useful to read about Mounjaro and IBS, or how the medicine is approached for people with gallstones or no gallbladder, as these pages cover related considerations around GI health and tirzepatide.

When you are managing both ulcerative colitis and a weekly injectable medicine, spotting patterns in how you feel becomes especially valuable. GLP Trackr's side-effect tracking feature lets you log GI symptoms — nausea, bloating, urgency, abdominal pain — on the days they occur, so over time you can see whether they cluster around your injection day, ease as weeks progress, or appear unrelated to your dose schedule. That kind of timestamped record is far more useful to bring to your prescriber than trying to recall how things felt over the past month.

The app also includes a doctor report feature that pulls together your logged symptoms, weight trend, and dose history into a summary you can share at appointments — making it easier for your clinical team to see the full picture of how you are getting on.

GLP Trackr is a tracking and journaling companion, not a medical service. It does not interpret your symptoms or advise on your treatment — that is your prescriber's role. But the records you keep inside the app can support much more informed conversations with your healthcare team.

Always follow your prescriber or doctor's guidance on whether to continue, adjust, or pause Mounjaro if your ulcerative colitis symptoms change. If anything feels severe or significantly different from your usual experience, reach out to a healthcare professional promptly rather than relying on self-monitoring alone.

To understand more about how tirzepatide works in the body, visit our overview on how Mounjaro works.

Ready to keep a clearer record of how your body is responding? GLP Trackr is available on the App Store and Google Play — try it free for 7 days and see how tracking your symptoms week by week can support the conversations that matter most.